Montreal prognostic score: estimating survival of patients with non-small cell lung cancer using clinical biomarkers

por Gagnon, B, Agulnik, J S, Gioulbasanis, I, Kasymjanova, G, Morris, D, MacDonald, N
Publicado 2013

Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer

por Gagnon, B, Abrahamowicz, M, Xiao, Y, Beauchamp, M-E, MacDonald, N, Kasymjanova, G, Kreisman, H, Small, D
Publicado 2010

P31.01 Impact of COVID-19 on Lung Cancer Diagnosis and Treatment: A Retrospective Chart Review

por Kasymjanova, G., Anwar, A., Sakr, L., Cohen, V., Small, D., Wang, H., Sultanem, K., Pepe, C., Friedmann, J., Agulnik, J.
Publicado 2021

EP06.01-001 The Longitudinal Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Centre: A Retrospective Chart Review

por Rizzolo, A., Kasymjanova, G., Pepe, C., Friedmann, J.E., Small, D., Price-Gallagher, C., Spicer, J., Sirois, C., Lecavalier-Barsoum, M., Khalil, S., Wang, H., Spatz, A., Cohen, V., Agulnik, J.
Publicado 2022